Glimzab MP 2mg/500mg/15mg Tablet
Marketer
Neucure Lifesciences Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimzab MP 2mg/500mg/15mg Tablet
Metformin/Glibenclamide/Pioglitazone 2mg/500mg/15mg tablets are a triple-combination medication managing blood glucose. This treatment, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It optimizes insulin effectiveness, reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Administer with food to prevent digestive discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in this case, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Kidney function tests will be assessed before commencing treatment. Limit alcohol consumption as it may exacerbate side effects.
Uses of Glimzab MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimzab MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimzab MP 2mg/500mg/15mg tablet should be administered with a meal.
Common Side effects of Glimzab MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimzab MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimzab MP 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Glimzab MP 2mg/500mg/15mg Tablet works:
Glimzab MP 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimzab MP 2mg/500mg/15mg tablets is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimzab MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimzab MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Glimzab MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimzab MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Glimzab MP 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimzab MP 2mg/500mg/15mg Tablet :
Should you forget a Glimzab MP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimzab MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently